Experts call for more guidance from FDA on registries in oncology
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsHealth Authority meeting and communication strategyPatient registriesPharmaceuticalsProduct developmentRegulatory Intelligence/PolicyRWE/RWDUnited StatesUS Food and Drug Administration (FDA)